Stryker Wingspan Stent System: Safety Communication – Narrowed Indications for Use

by FDA on August 8, 2012

in MedWatch

Wingspan may present unacceptable risks, such as stroke and death, to many patients previously considered appropriate for treatment with Wingspan.

This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.

View Full Details Of The Original MedWatch Notice Here.

Leave a Comment

Previous post:

Next post: